GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED
LAXMI HOUSE 2-B DRAYCOTT AVENUE, KENTON, HARROW  HA3 0BU- Active - Proposal to Strike off
- Private Limited Company
- Company No. 06420547
- Last Updated: 01 Dec 2021
Company Profile
GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED was incorporated on Wednesday, November 7, 2007 as a Private Limited Company with registered address in HARROW. GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED has the status: Active - Proposal to Strike off and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 17 years 3 months and 15 days.
Name | GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED |
---|---|
Company number | 06420547 |
Company type | Private Limited Company |
Incorporation date | 07 Nov 2007 |
Status | Active - Proposal to Strike off |
Industry (SIC 2007) |
Address
Registered Address |
LAXMI HOUSE 2-B DRAYCOTT AVENUE KENTON HARROW HA3 0BU |
---|---|
Country Of Origin |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Glenn Saldanha Nationality: Indian |
Dates: Wednesday, April 6, 2016 - present
significant influence or control
|
Ms Blanche Elizabeth Saldanha Nationality: Indian |
Dates: Wednesday, April 6, 2016 - present
ownership of shares 25 to 50 percent as trust
|
Mrs Cherylann Pinto Nationality: Indian |
Dates: Wednesday, April 6, 2016 - present
ownership of shares 25 to 50 percent as trust
|
Accounts and Confirmation
Type of accounts | SMALL |
---|---|
End of financial Year | 31 March |
Next annual accounts due | 31 December 2021, (-1149 days left) |
Latest accounts | 31 March 2020 |
Next confirmation statement due | 05 December 2016 |
Last confirmation statement dated | 07 November 2015 |
Mortgages
No mortgages have been registered against GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED.
Previous Names
Name | Change Date |
---|---|
GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED | 07 Nov 2007 |
NEWINCCO 778 LIMITED | 15 Jan 2008 |
GLENMARK PHARMACEUTICALS EUROPE LIMITED | 29 Nov 2013 |